Site search

World-first clot-busting drug trial improves patient care on Mobile Stoke Unit News article

A randomised controlled drug trial suggests clot-busting drug Tenecteplase provides better outcomes for stroke patients compared to the current standard of care alteplase.  

Education programs

Our Medical Education Unit collaborates with internal and external experts to provide a range of educational opportunities.

The RMH launches new service supporting ‘silver trauma’ patients News article

In an Australian-first, the Royal Melbourne Hospital (RMH) has launched a new service to support older trauma patients.

Good Clinical Practice training

The Good Clinical Practice (GCP) guideline is the international ethics and scientific quality standard for conducting clinical trials

New surgical pathways helping patients return home sooner News article

Patients undergoing planned surgery will be able to return home sooner thanks to the support of our 'hospital in the home' service.

The RMH patient, Elias Frantzeskos celebrates DonateLife Week News article

Elias Frantzeskos came into the world 7 weeks early with poor function of his kidney.

Post-Approval Management

Our organisation, the ethics committee and investigators must ensure that the research continues to conform to approved ethical standards, and in accordance with the Royal Melbourne Hospital (RMH) Research Policy throughout its lifecycle.

Your medication

When you come to hospital, bring your medication with you, including non-prescription or complementary therapy medicines.

Mental health social work

Social workers are the largest allied health workforce in public mental health, employed in a range of roles at all levels of the organisation.

Learn about heart failure

Heart failure is a condition where the heart doesn’t pump blood to the rest of your body the way it should. This means your organs and muscles don’t get enough oxygen to function properly.

Stroke patient thankful for MSU News article

It was Geoff’s young grandson who first noticed that something wasn’t quite right with his grandfather. After his family called triple zero (000), the Mobile Stroke Unit (MSU) was dispatched. (Photo: Herald Sun)

OPT-302 with ranibizumab for neovascular age-related macular degeneration Research study

The ShORe trial aims to determine if the investigational medication OPT-302 will improve vision for people with wet age-related macular degeneration (AMD) when given in combination with ranibizumab, compared to ranibizumab alone.

Our Clinical Trials Centre

The Clinical Trials Centre (CTC) is a dedicated purpose-built space for conducting clinical trials. All clinical trial visits at the Royal Melbourne Hospital take place in this space.

Section 4: If your project is a clinical trial investigating a drug or device

Complete section 4 only if your project is a clinical trial investigating a drug and/or device.

Atopic Dermatitis Research study

The research study is testing an investigational product called TAVO101 designed specifically for people diagnosed with moderate to severe atopic dermatitis (eczema),

Nemolizumab for the treatment of moderate to severe atopic dermatitis Research study

A clinical trial to assess safety and effectiveness of a new drug for eczema called nemolizumab.

Thinking about donating a kidney

Considering donating a kidney? We have a dedicated team of of experts who can answer your questions and guide you through the decision to become a kidney donor.

Cognitive Dementia and Memory Service RMH Service

We provide diagnosis and support to people experiencing changes in their thinking, behaviour or memory.

Donanemab in early symptomatic Alzheimer’s disease Research study

A study to determine the safety and efficacy of a drug called donanemab in treating or delaying the progression of Alzheimer’s dementia.

Continuous glucose monitoring

We offer a continuous glucose monitoring service for our patients.